Keyu Chen

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 8

Top Topics

Polycystic Ovary Syndrome

Patient Reported Outcomes

Advanced Non Small Cell Lung Cancer

Chemotherapy Induced

Top Venues

Technology in cancer research & treatment

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Wang, Jiayi Wu, Keyu Chen, Xiao-Jia Wang, Xiying Shao
Prognostic Parameters of Palbociclib in HR+/HER2- Advanced Breast Cancer: A Narrative Review. Technology in cancer research & treatment 22 (2023)
Keyu Chen, Jiaojiao Xu, Wei Wang, Ruiyuan Jiang, Huanping Zhang, Xiaojia Wang, Jun Cao, Meiyu Fang
Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study. Cancer medicine (2023)
Keyu Chen, Jiaojiao Xu, Wei Wang, Ruiyuan Jiang, Huanping Zhang, Xiaojia Wang, Jun Cao, Meiyu Fang
Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study. Cancer medicine (2023)
Wei Wang, Jiayi Wu, Keyu Chen, Xiao-Jia Wang, Xiying Shao
Prognostic Parameters of Palbociclib in HR+/HER2- Advanced Breast Cancer: A Narrative Review. Technology in cancer research & treatment 22 (2023)
Keyu Chen, Jiayi Wu, Ziru Fang, Xiying Shao, Xiaojia Wang
The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer. Technology in cancer research & treatment 21 (2023)
Keyu Chen, Jiaojiao Xu, Wei Wang, Ruiyuan Jiang, Huanping Zhang, Xiaojia Wang, Jun Cao, Meiyu Fang
Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study. Cancer medicine (2023)
Keyu Chen, Jiaojiao Xu, Wei Wang, Ruiyuan Jiang, Huanping Zhang, Xiaojia Wang, Jun Cao, Meiyu Fang
Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study. Cancer medicine (2023)
Wei Wang, Jiayi Wu, Keyu Chen, Xiao-Jia Wang, Xiying Shao
Prognostic Parameters of Palbociclib in HR+/HER2- Advanced Breast Cancer: A Narrative Review. Technology in cancer research & treatment 22 (2023)